PDS Biotechnology Corp (PDSB) stock
PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.89−0.03 (-3.28%)
Close on Nov 17, 2026Market cap $50.03MP/E –Yield –
PDS Biotechnology price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
PDS Biotechnology's price to book ratio was 9.8× on Jul 31, 2026, against 2.2× a year earlier. Over the last 5 years it ranged from 1.6× to 15.5×, with a median of 3.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 9.8× | +6.0 |
| 2025 | Dec 31, 2025 | 3.9× | +1.2 |
| 2024 | Dec 31, 2024 | 2.7× | −3.6 |
| 2023 | Dec 29, 2023 | 6.3× | −1.7 |
| 2022 | Dec 30, 2022 | 8.0× | +4.6 |
| 2021 | Dec 31, 2021 | 3.4× | +1.9 |
| 2020 | Dec 31, 2020 | 1.5× | +0.6 |
| 2019 | Dec 31, 2019 | 0.9× | −9.6 |
| 2018 | Jan 31, 2018 | 10.5× | +2.8 |
| 2017 | Dec 29, 2017 | 7.7× | +0.3 |
| 2016 | Dec 30, 2016 | 7.4× | – |
See a number that looks wrong?